amiloride has been researched along with Cirrhosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gimenez, G; Mehta, PM; Slatter, TL; Walker, RJ | 1 |
| MacWalter, RS; McSwiggan, S; Ogston, SA; Struthers, AD; Sze, KY; Wong, KY; Wong, SY | 1 |
| Bedford, JJ; Kalita-De Croft, P; Leader, JP; Walker, RJ | 1 |
| Arrieta, J; Escanero, J; Guerra, M; Moina, I; Soria, M; Ugarte, I | 1 |
| Campbell, SE; Janicki, JS; Matsubara, BB; Weber, KT | 1 |
| Brown, L; Fenning, A; Margolin, SB; Mirkovic, S; Seymour, AM; Strachan, A; Taylor, SM | 1 |
1 trial(s) available for amiloride and Cirrhosis
| Article | Year |
|---|---|
Myocardial fibrosis and QTc are reduced following treatment with spironolactone or amiloride in stroke survivors: a randomised placebo-controlled cross-over trial.
Topics: Aged; Amiloride; Cross-Over Studies; Diuretics; Double-Blind Method; Female; Fibrosis; Heart Diseases; Humans; Hypertrophy, Left Ventricular; Long QT Syndrome; Male; Placebos; Potassium; Procollagen; Spironolactone; Stroke; Survivors; Treatment Outcome | 2013 |
5 other study(ies) available for amiloride and Cirrhosis
| Article | Year |
|---|---|
Reduction of lithium induced interstitial fibrosis on co-administration with amiloride.
Topics: Amiloride; Animals; Fibrosis; Inflammation; Kidney; Lithium; Lung Diseases, Interstitial; Rats | 2022 |
Amiloride modifies the progression of lithium-induced renal interstitial fibrosis.
Topics: Amiloride; Animals; beta Catenin; Collagen Type III; Connective Tissue Growth Factor; Cytoprotection; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Disease Progression; Epithelial Sodium Channel Blockers; Fibrosis; Glycogen Synthase Kinase 3 beta; Kidney; Kidney Diseases; Lithium Carbonate; Male; Myofibroblasts; Rats, Wistar; Transforming Growth Factor beta1 | 2018 |
[Intracellular pH changes induced by sclerosing agents in peritoneal fibroblasts].
Topics: Acetates; Amiloride; Animals; Cadmium; Calcium-Transporting ATPases; Cells, Cultured; Dialysis Solutions; Fibroblasts; Fibrosis; Glucose; Hydrogen-Ion Concentration; Hypertonic Solutions; Interleukin-1; Intracellular Fluid; Ion Transport; Lactates; Peritoneal Dialysis; Peritoneum; Peritonitis; Rats; Rats, Wistar; Sclerosing Solutions; Sclerosis; Sodium-Hydrogen Exchangers | 2004 |
Myocardial fibrosis in the rat with mineralocorticoid excess. Prevention of scarring by amiloride.
Topics: Aldosterone; Amiloride; Animals; Cardiomyopathies; Cicatrix; Collagen; Disease Models, Animal; Drug Therapy, Combination; Fibrosis; Hypertension; Hypertrophy; Male; Mineralocorticoids; Myocardium; Necrosis; Rats; Rats, Sprague-Dawley; Time Factors | 1993 |
Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats.
Topics: Amiloride; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta, Thoracic; Biological Availability; Collagen; Desoxycorticosterone; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Myocardium; Norepinephrine; Pyridones; Rats; Rats, Wistar; Sodium Chloride, Dietary; Vasoconstrictor Agents | 2002 |